The DOI matches its Crossref record; 133 of the 133 references it cites were found in a registry or an index.
B Cells in Rheumatoid Arthritis:Pathogenic Mechanisms and Treatment Prospects
Open accessAbstract
Rheumatoid arthritis (RA) is a common, chronic, systemic autoimmune disease, and its clinical features are the proliferation of joint synovial tissue, the formation of pannus and the destruction of cartilage. The global incidence of RA is about 1%, and it is more common in women. The basic feature of RA is the body’s immune system disorders, in which autoreactive CD4+T cells, pathogenic B cells, M1 macrophages, inflammatory cytokines, chemokines and autoantibodies abnormally increase in the body of RA patients B cell depletion therapy has well proved the important role of B cells in the pathogenesis of RA, and the treatment of RA with B cells as a target has also been paid more and more attention. Although the inflammatory indicators in RA patients receiving B-cell depletion therapy have been significantly improved, the risk of infection and cancer has also increased, which suggests that we need to deplete pathogenic B cells instead of all B cells. However, at present we cannot distinguish between pathogenic B cells and protective B cells in RA patients. In this review, we explore fresh perspectives upon the roles of B cells in the occurrence, development and treatment of RA.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Pathogenesis of Rheumatoid Arthritis
McInnes, I. B., & Schett, G. (2011) · New England Journal of Medicine · doi:10.1056/nejmra1004965 · Cited by 5,514 · cited 1×
“TNF-a can increase the expression of RANKL by B cells in the presence of IL-1b, thereby promoting the formation of osteoclasts (69).”
Background(2008) · doi:10.1038/nrg2290 · Cited by 5,199
Rantapää‐Dahlqvist, S., de Jong, B. A. W., Berglin, E., Hallmans, G., Wadell, G., Stenlund, H., Sundin, U., & van Venrooij, W. J. (2003) · Arthritis & Rheumatism · doi:10.1002/art.11223 · Cited by 1,953
Immunopathogenesis of Rheumatoid Arthritis
Firestein, G. S., & McInnes, I. B. (2017) · Immunity · doi:10.1016/j.immuni.2017.02.006 · Cited by 1,301
Yanaba, K., Bouaziz, J.-D., Haas, K. M., Poe, J. C., Fujimoto, M., & Tedder, T. F. (2008) · Immunity · doi:10.1016/j.immuni.2008.03.017 · Cited by 1,238
Iwata, Y., Matsushita, T., Horikawa, M., DiLillo, D. J., Yanaba, K., Venturi, G. M., Szabolcs, P. M., Bernstein, S. H., Magro, C. M., Williams, A. D., et al. (2011) · Blood · doi:10.1182/blood-2010-07-294249 · Cited by 1,104
Christensen, S. R., Shupe, J., Nickerson, K., Kashgarian, M., Flavell, R. A., & Shlomchik, M. J. (2006) · Immunity · doi:10.1016/j.immuni.2006.07.013 · Cited by 1,090
Characterization of a human B lymphocyte-specific antigen.
Stashenko, P., Nadler, L. M., Hardy, R., & Schlossman, S. F. (1980) · The Journal of Immunology · doi:10.4049/jimmunol.125.4.1678 · Cited by 1,076
Shen, P., Roch, T., Lampropoulou, V., O’Connor, R. A., Stervbo, U., Hilgenberg, E., Ries, S., Dang, V. D., Jaimes, Y., Daridon, C., et al. (2014) · Nature · doi:10.1038/nature12979 · Cited by 1,048
Thien, M., Phan, T. G., Gardam, S., Amesbury, M., Basten, A., Mackay, F., & Brink, R. (2004) · Immunity · doi:10.1016/j.immuni.2004.05.010 · Cited by 746
Research works printed but not linked: 15
- Zhang, 2021, BAFF, Involved in B Cell Activation Through the NF-kappaB Pathway, Is Related to Disease Activity and Bone Destruction in Rheumatoid Arthritis, Acta Pharmacol Sin, 10.1038/s41401-020-00582-4 · doi:10.1038/s41401-020-00582-4
- Zhao, 2014, The Role of a Proliferation-Inducing Ligand (APRIL) in the Pathogenesis of Rheumatoid Arthritis, Scand J Rheumatol, 43, 10.3109/03009742.2014.905630 · doi:10.3109/03009742.2014.905630
- Wu, 2020, Nanoparticle-Facilitated Delivery of BAFF-R siRNA for B Cell Intervention and Rheumatoid Arthritis Therapy, Int Immunopharmacol, 88, 106933, 10.1016/j.intimp.2020.106933 · doi:10.1016/j.intimp.2020.106933
- Dam, 2018, Increased Binding of Specificity Protein 1 to the IL21R Promoter in B Cells Results in Enhanced B Cell Responses in Rheumatoid Arthritis, Front Immunol, 9, 10.3389/fimmu.2018.01978 · doi:10.3389/fimmu.2018.01978
- Kleinau, 2003, The Impact of Fc Receptors on the Development of Autoimmune Diseases, Curr Pharm Des, 9, 10.2174/1381612033454414 · doi:10.2174/1381612033454414
- Hu, 2021, Yishen-Tongbi Decoction Inhibits Excessive Activation of B Cells by Activating the FcgammaRIIb/Lyn/SHP-1 Pathway and Attenuates the Inflammatory Response in CIA Rats, BioMed Pharmacother, 134, 111166, 10.1016/j.biopha.2020.111166 · doi:10.1016/j.biopha.2020.111166
- Sauer, 2012, Defective B Cell Tolerance in Adenosine Deaminase Deficiency Is Corrected by Gene Therapy, J Clin Invest, 122, 10.1172/JCI61788 · doi:10.1172/jci61788
- Detanico, 2013, Somatic Mutagenesis in Autoimmunity, Autoimmunity, 46, 10.3109/08916934.2012.757597 · doi:10.3109/08916934.2012.757597
- Malmstrom, 2018, The Parallel Worlds of ACPA-Positive and RF-Positive B Cells, Nat Rev Rheumatol, 14, 10.1038/s41584-018-0094-5 · doi:10.1038/s41584-018-0094-5
- Auger, 2020, Peptidylarginine Deiminase Autoimmunity and the Development of Anti-Citrullinated Protein Antibody in Rheumatoid Arthritis: The Hapten-Carrier Model, Arthritis Rheumatol, 72, 10.1002/art.41189 · doi:10.1002/art.41189
- Chirivi, 2013, Anti-Citrullinated Protein Antibodies as Novel Therapeutic Drugs in Rheumatoid Arthritis, J Clin Cell Immunol, 1, 10.4172/2155-9899.S6-006 · doi:10.4172/2155-9899.s6-006
- Usha, 2017, In Vitro Allogeneic Immune Cell Response to Mesenchymal Stromal Cells Derived From Human Adipose in Patients With Rheumatoid Arthritis, Cell Immunol, 314, 18, 10.1016/j.cellimm.2017.01.008 · DOI
- Noguchi, 2020, Anti-Cyclic Citrullinated Peptide Antibody Titers Decrease in Rheumatoid Arthritis Patients Treated With Tocilizumab: A Pilot Study, Mod Rheumatol, 30, 10.1080/14397595.2019.1583784 · doi:10.1080/14397595.2019.1583784
- Martina, 2016, Inhibition of JAK3 and PKC via Immunosuppressive Drugs Tofacitinib and Sotrastaurin Inhibits Proliferation of Human B Lymphocytes In Vitro, Transplant Proc, 48, 10.1016/j.transproceed.2016.07.052 · doi:10.1016/j.transproceed.2016.07.052
- Sonomoto, 2014, Effects of Tofacitinib on Lymphocytes in Rheumatoid Arthritis: Relation to Efficacy and Infectious Adverse Events, Rheumatol (Oxford), 53, 10.1093/rheumatology/ket466 · doi:10.1093/rheumatology/ket466
Cited by
Rheumatoid Arthritis: Pathogenic Roles of Diverse Immune Cells
Jang, S., Kwon, E.-J., & Lee, J. J. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23020905 · Cited by 612
Radiopharmaceuticals for PET and SPECT Imaging: A Literature Review over the Last Decade
Crișan, G., Moldovean-Cioroianu, N. S., Timaru, D.-G., Andrieș, G., Căinap, C., & Chiș, V. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23095023 · Cited by 337
Kalidass, B., Murugesan, K., Shanmugam, A., Kaveri, P. K., & Lakshmanan, D. K. (2026) · Cellular Immunology · doi:10.1016/j.cellimm.2026.105129
Metadata
- Authors
- Wu, F., Gao, J., Kang, J., Wang, X., Niu, Q., Liu, J., & Zhang, L.
- Venue
- Frontiers in Immunology
- Publisher
- Frontiers Media SA
- Published
- 2021-09-28
- Volume
- 12
- Pages
- 750753-750753
- ISSN
- 1664-3224 (ISSN-L)
- OpenAlex
- W3204655672
- Cited by
- 267
- References
- 133
- FWCI
- 23.27
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: B Cells in Rheumatoid Arthritis:Pathogenic Mechanisms and Treatment Prospects. https://app.cochat.ai/papers/10.3389/fimmu.2021.750753
- The paper
- Wu, F., Gao, J., Kang, J., Wang, X., Niu, Q., Liu, J., & Zhang, L. (2021). B Cells in Rheumatoid Arthritis:Pathogenic Mechanisms and Treatment Prospects. Frontiers in Immunology. https://doi.org/10.3389/fimmu.2021.750753
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.